# Advancing Clinical Heart Failure Outcomes Leveraging Defibrillation Lead Implant System for Left Bundle Branch Area Pacing

Study · id `cardio:ct-nct07526896` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT07526896](<https://clinicaltrials.gov/study/NCT07526896>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT07526896

Browse, organ or system: Heart  
Browse, condition area: Heart failure  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 110 participants.

## Technical summary

Registry record NCT07526896. Randomized; double masking; primary purpose treatment. Start 2026-10-13 (actual); primary completion 2029-07 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; double masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 110 participants (planned count; ClinicalTrials.gov record NCT07526896, source copy `cardio:ctgov-nct07526896-2026-10-20`, retrieved 2026-10-26)
- Started: 2026-10-13 (actual) (ClinicalTrials.gov record NCT07526896, source copy `cardio:ctgov-nct07526896-2026-10-20`, retrieved 2026-10-26)
- Primary completion: 2029-07 (anticipated) (ClinicalTrials.gov record NCT07526896, source copy `cardio:ctgov-nct07526896-2026-10-20`, retrieved 2026-10-26)
- Completion: 2029-09 (anticipated) (ClinicalTrials.gov record NCT07526896, source copy `cardio:ctgov-nct07526896-2026-10-20`, retrieved 2026-10-26)
- Countries: United States (ClinicalTrials.gov record NCT07526896, source copy `cardio:ctgov-nct07526896-2026-10-20`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct07526896-2026-10-20`, retrieved 2026-10-26)

## The registry's words

- Brief title: Advancing Clinical Heart Failure Outcomes Leveraging Defibrillation Lead Implant System for Left Bundle Branch Area Pacing
- Acronym: ACHIEVED LBBAP
- Condition: Heart Failure
- Condition: Systolic Bundle Branch Block, Left
- Intervention (Device): LBBAP Therapy
- Intervention (Device): LOT-CRT
- Intervention (Device): ICD
- Intervention (Device): LOT-CRT
- Lead sponsor: Medtronic Cardiac Rhythm and Heart Failure
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Heart failure (`cardio:heart-failure`)
- Registry lists this organization as the lead sponsor: Medtronic Cardiac Rhythm and Heart Failure (`cardio:org-medtronic-cardiac-rhythm-and-heart-failure`)

## Provenance

Content hash: 560ee9b3e1e50342cd02e2d690800e60d4a42ef808b3d522fde2d63245a900f1
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
